AbCellera Biologics Inc. (ABCL)

AI Score

Unlock

2.42

0.03 (1.26%)

At close: Apr 17, 2025, 3:59 PM

2.41

-0.41%

After-hours: Apr 17, 2025, 06:43 PM EDT

AbCellera Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	156.32M	126.64M	173.31M	148.57M	133.32M	172.42M	179.75M	193.02M	386.54M	371.97M	790.62M	545.72M	476.14M	517.69M	792.57M	685.79M	594.12M	91.08M	113.14M	-7.55M	7.55M	-10.44M
Short-Term Investments	469.29M	516.5M	522.04M	574.45M	627.26M	613.42M	615.95M	603.48M	499.95M	496.23M	231.65M	240.34M	246.84M	235.78M	n/a	n/a	n/a	594.12M	19.25M	15.11M	594.12M	20.89M
Long-Term Investments	82.3M	84.08M	130.76M	122.09M	65.94M	62.89M	58.79M	57.58M	72.52M	66.72M	65.82M	58.88M	50.31M	47.51M	42.7M	32.19M	19.25M	19.25M	n/a	n/a	19.25M	n/a
Other Long-Term Assets	96.54M	134.22M	57.81M	54.43M	94.24M	80.69M	113.45M	89.84M	46.33M	49.07M	43.84M	43.39M	23.23M	31.62M	15.95M	9.55M	2.49M	-151.79M	1.32M	-7.55M	584.78K	-10.44M
Receivables	92.13M	63.24M	67.7M	68.78M	64.38M	75.48M	86.23M	99.57M	103.41M	105.96M	52.8M	334.4M	160.58M	43.63M	65.31M	216.69M	213.24M	20.11M	292.35K	n/a	4.38M	n/a
Inventory	n/a	n/a	1.00	738K	1.11M	1.19M	1.45M	1.45M	1.53M	25M	25M	25M	1.67M	1.33M	1.21M	1.21M	1.41M	1.03M	-1	n/a	594.12M	n/a
Other Current Assets	33.63M	36.51M	33.49M	21.41M	45.91M	25M	25M	25M	25M	71.5M	68.89M	53.92M	39.28M	n/a	62.51M	193.32M	489K	2.81M	14.23M	n/a	337.00	n/a
Total Current Assets	751.37M	742.88M	771.55M	813.95M	871.99M	919.52M	930.74M	940.65M	1.03B	1.05B	1.14B	1.17B	929.8M	803.75M	864M	907.98M	813.33M	114M	128.7M	7.55M	12.64M	10.44M
Property-Plant & Equipment	340.43M	331.26M	318.88M	306.08M	287.7M	277.21M	259.64M	233.19M	217.25M	200.6M	149.18M	122.05M	111.62M	91.58M	87.48M	34.62M	17.92M	14.28M	11.62M	n/a	8.48M	n/a
Goodwill & Intangibles	89.92M	100.38M	133.47M	166.54M	168.23M	171.88M	174.55M	176.65M	179.31M	190.35M	190.99M	193.59M	196.2M	198.28M	141.72M	144.19M	146.65M	13.9M	13.57M	n/a	146.65M	n/a
Total Long-Term Assets	609.18M	649.95M	640.93M	649.15M	616.11M	592.67M	606.43M	557.27M	515.42M	506.74M	449.83M	417.91M	388.77M	368.99M	287.85M	220.54M	192.21M	28.39M	26.51M	-7.55M	10.85M	-10.44M
Total Assets	1.36B	1.39B	1.41B	1.46B	1.49B	1.51B	1.54B	1.5B	1.54B	1.55B	1.59B	1.59B	1.32B	1.17B	1.15B	1.13B	1.01B	142.39M	155.22M	n/a	23.49M	n/a
Account Payables	34.35M	34.8M	26.59M	26.91M	25.51M	17.43M	21.02M	17.57M	14.83M	9.32M	10.31M	10.35M	14.92M	8.91M	5.61M	3.58M	7.32M	2.99M	2.52M	n/a	1.64M	n/a
Deferred Revenue	13.52M	5.58M	6.4M	10.56M	26.07M	23.86M	15.06M	18.39M	27.9M	13.1M	10.39M	14.24M	7.54M	10.12M	10.57M	11.31M	6.59M	6.92M	6.59M	n/a	3.24M	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	190K	319.55K	362.17K	n/a	2.47M	n/a
Other Current Liabilities	20.65M	28.08M	27.43M	59.03M	60.68M	63.38M	79.53M	52.55M	n/a	79.66M	197.9M	183.56M	54.85M	33.63M	43.2M	41.94M	50.77M	9.88M	8.36M	n/a	3.36M	n/a
Total Current Liabilities	76.61M	79.57M	70.38M	104.88M	119.01M	110.24M	118.91M	89.59M	118.32M	106.05M	221.14M	213.42M	120.68M	49.55M	69.76M	88.39M	103.49M	20.1M	18.27M	n/a	7.89M	n/a
Long-Term Debt	60.74M	n/a	124.19M	-110.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.2M	1.94M	16.37M	n/a	1.36M	n/a
Other Long-Term Liabilities	80.45M	156.11M	134.97M	-99.78M	106.73M	10.36M	8.11M	18.7M	19.14M	28.25M	27.61M	34.05M	37.62M	46.64M	11.27M	10.31M	13.57M	4.32M	26.69M	n/a	61.00	n/a
Total Long-Term Liabilities	151.25M	235.17M	106.95M	117.72M	216.76M	219.18M	223.43M	199.83M	189.31M	196.19M	159.79M	171.36M	172.16M	169.79M	114.42M	83M	71.54M	33.04M	46.05M	n/a	5.34M	n/a
Total Liabilities	304.47M	314.73M	177.33M	222.6M	335.78M	329.42M	342.34M	289.42M	307.63M	302.24M	380.93M	384.78M	292.84M	219.34M	184.18M	171.4M	175.03M	53.15M	64.32M	n/a	13.24M	n/a
Total Debt	60.74M	71.4M	72.05M	73.61M	77.38M	80.76M	84.03M	83.13M	82.26M	76.11M	36.78M	40.28M	36.41M	30.06M	31.02M	16.97M	6.1M	5.32M	19.73M	n/a	6.89M	n/a
Common Stock	777.17M	772.83M	769.97M	764.56M	753.2M	747.91M	744.76M	742.82M	734.37M	730.43M	726.83M	725.75M	722.43M	718.09M	714.76M	711.14M	710.39M	88.58M	5.37M	n/a	5.12M	n/a
Retained Earnings	n/a	151.14M	202.25M	239.18M	279.79M	326.94M	355.55M	386.07M	426.19M	456.08M	429.45M	436.24M	267.67M	207.72M	229.1M	231.42M	114.2M	-2.8M	-105.54K	n/a	-4.72M	n/a
Comprehensive Income	-4.38M	-1.23M	-2.07M	-1.82M	-1.72M	-1.46M	-1.9M	-2.02M	-1.39M	-717K	576K	787K	280K	644K	2.15M	n/a	0.00	-0.00	0.00	2.71M	-3.16M	4.05M
Shareholders Equity	1.06B	1.08B	1.11B	1.13B	1.15B	1.18B	1.19B	1.21B	1.23B	1.25B	1.21B	1.21B	1.03B	953.4M	967.68M	957.12M	830.51M	89.24M	90.89M	10.25M	10.25M	11.61M
Total Investments	551.59M	600.58M	652.81M	696.54M	693.2M	676.3M	674.74M	661.06M	572.47M	562.95M	297.48M	299.22M	297.15M	283.29M	42.7M	32.19M	19.25M	613.36M	19.25M	15.11M	613.36M	20.89M